Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 10.30 Exhibit 10.30
- 10.31 Exhibit 10.31
- 10.32 Exhibit 10.32
- 10.33 Exhibit 10.33
- 10.34 Exhibit 10.34
- 10.35 Exhibit 10.35
- 10.36 Exhibit 10.36
- 10.37 Exhibit 10.37
- 10.38 Exhibit 10.38
- 10.39 Exhibit 10.39
- 10.40 Exhibit 10.40
- 16.1 Exhibit 16.1
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 99.6 Exhibit 99.6
- 99.7 Exhibit 99.7
- 99.8 Exhibit 99.8
- 99.9 Exhibit 99.9
- 99.10 Exhibit 99.10
- 99.11 Exhibit 99.11
- 99.12 Exhibit 99.12
- EX-FILING FEES Filing Fees Table
- Download Excel data file
- View Excel data file
Associated filings
- 5 Dec 22 424B3 Prospectus supplement
- 14 Nov 22 EFFECT Notice of effectiveness
- 10 Nov 22 424B3 Prospectus supplement
- 4 Nov 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 24 Oct 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 3 Oct 22 S-4/A Registration of securities issued in business combination transactions (amended)
-
29 Aug 22 S-4 Registration of securities issued in business combination transactions
KANT similar filings
- 4 Nov 22 Registration of securities issued in business combination transactions (amended)
- 24 Oct 22 Registration of securities issued in business combination transactions (amended)
- 3 Oct 22 Registration of securities issued in business combination transactions (amended)
- 29 Aug 22 Registration of securities issued in business combination transactions
- 6 Nov 20 Registration of securities issued in business combination transactions (amended)
- 28 Oct 20 Registration of securities issued in business combination transactions (amended)
- 23 Sep 20 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-4 of Yumanity Therapeutics, Inc. of our report dated March 24, 2022 relating to the financial statements of Yumanity Therapeutics, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
August 26, 2022